Certara Launches COVID-19 Clinical Outcomes Database
Certara, the global leader in biosimulation, announced today that it has launched the COVID-19 Clinical Outcomes Database to provide up-to-date information on the results of COVID-19 clinical trials and observational studies, worldwide.
- Certara, the global leader in biosimulation, announced today that it has launched the COVID-19 Clinical Outcomes Database to provide up-to-date information on the results of COVID-19 clinical trials and observational studies, worldwide.
- The COVID-19 Clinical Outcomes Database will help to determine the viability of potential therapeutics and vaccines for COVID-19 by using relevant data from more than 500 registered COVID-19 studies, worldwide, over the next three months.
- The database can be accessed through Certaras interactive Clinical Outcomes Database Explorer (CODEx) interface, an online platform that enables visualization, exploration, and analysis of data.
- The COVID-19 Clinical Outcomes Database is one of over 45 clinical trial outcomes databases developed by Certara across therapeutic areas such as cardiovascular diseases, immunology, and oncology.